The
significance of this social change blog is that it will identify the need for
recognition of the condition and its scope, promote education of patients and
providers and therefore influence earlier detection and correct treatment, and
to advocate for more specific research, eventually, into the biochemical,
cellular, and genetic aspects. In addition, throughout understanding of how
PCPs experience treating MDD and other mood disorders, a more efficient
treatment paradigm can be suggested. This topic can explore whether or not
there is probability that an improved paradigm for treating mood dysfunction
exists and can be readily implemented within the primary care setting (Thota
et al., 2012).
Furthermore, exploration of a model of management based on physiology and
genetic predisposition that could hopefully further destigmatize the diagnosis
of depression and mood instability, lead to broader access to treatment, and
improve outcomes. Lastly, the impact of our healthcare changes can also be
examined.
No comments:
Post a Comment